December 2, 2024 - 21:36

TORONTO, December 02, 2024 – In a significant leadership change, Westaim Corporation has announced the appointment of Matthew Skurbe as its new Chief Financial Officer (CFO) and Chief Risk Officer (CRO). Skurbe brings a wealth of experience to the role, having previously held various senior financial and risk management positions across multiple industries.
In his new capacity, Skurbe will be responsible for overseeing the company's financial strategy, ensuring robust financial health, and managing risk exposure effectively. His expertise in financial planning and analysis, along with his strong background in governance and compliance, positions him well to lead Westaim through its next phase of growth.
The appointment comes at a time when the company is focusing on expanding its operations and enhancing its market presence. The leadership team expressed confidence in Skurbe's ability to drive financial performance and navigate the complexities of risk management in today's dynamic business environment. Stakeholders are optimistic about the fresh perspective and strategic insight he will bring to the organization.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...